What We Do: Drug Policy Research
Established in 2008, the Ontario Drug Policy Research Network (ODPRN) is a collaboration between researchers and drug policy decision-makers across Ontario with the goal of responding rapidly to policymakers’ needs to provide timely, relevant and scientifically rigorous research. The ODPRN is a global leader in integrating evidence into policy-making to impact societal outcomes and improve healthcare system efficiency.
Learn More
COVID-19 Ontario Prescription Drug Utilization Tool: Update
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID-19 pandemic: A cross-sectional analysis of 66 countries
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
Where the parties stand: On the opioid crisis
Product label changes do not prevent accidental acetaminophen overdoses: Study
Antibiotic use varies across Canada’s provinces
St. Michael’s scientists receive over $2.6-million in two CIHR competitions to address key COVID-19- related questions